Publication: Nipple-areola complex sensation after nipple-sparing mastectomy
Issued Date
2018-04-01
Resource Type
ISSN
21697574
Other identifier(s)
2-s2.0-85053893681
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Plastic and Reconstructive Surgery - Global Open. Vol.6, No.4 (2018)
Suggested Citation
Prakasit Chirappapha, Pongsakorn Srichan, Panuwat Lertsithichai, Panya Thaweepworadej, Thongchai Sukarayothin, Monchai Leesombatpaiboon, Youwanush Kongdan Nipple-areola complex sensation after nipple-sparing mastectomy. Plastic and Reconstructive Surgery - Global Open. Vol.6, No.4 (2018). doi:10.1097/GOX.0000000000001716 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46764
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Nipple-areola complex sensation after nipple-sparing mastectomy
Other Contributor(s)
Abstract
© 2018 The Authors. Published by Wolters Kluwer Health, Inc. Background: Nipple-sparing mastectomy (NSM) has been proven to be oncologically safe for treating breast cancer. This procedure had been developed to optimize the esthetic outcome and reduce feeling mutilation after mastectomy. Risks of necrotic complications and diminishing nipple-areola complex (NAC) sensation are common complications affecting the patient's satisfaction after the surgery. The evaluation of NAC sensation should be also investigated. Methods: We prospectively analyzed 55 NSMs that were performed on 52 patients for both therapeutic and prophylactic indications in Ramathibodi Hospital from May 2007 to September 2015. Patients' demographics, operative details, oncologic outcome, and postoperative complications, focusing on NAC sensation and necrotic complications, were analyzed. Results: Forty-seven NSMs (87%) were performed for therapeutic indications, and another 7 NSMs (13%) were risk-reducing operations. Of the 43 patients performing NSM for breast cancer treatment, 33 patients (77%) had invasive cancer and 11 patients (23%) had ductal carcinoma in situ. One subareola base tissue was found an occult cancer, and the NAC was then removed. There were 3 locoregional recurrences after a median follow-up time of 24 months (range, 2-104 months). The NAC sensation was evaluated in a total of 35 patients. Twenty-five patients (46%) underwent serial evaluation after 6 months of operation, and 10 patients were evaluated at more than 1 year after operation. In the first 6 months, 11 patients (44%) showed partial sensation recovery, and 3 more patients had partial recovery after 1-year follow-up. Only 1 patient (2%) had complete sensation recovery in all area of the NAC. In late evaluation group, 7 out of 10 patients had partial recovery. Most pain sensation remained in the lower aspect of the areola away from surgical incision. Conclusions: NSM is technically feasible in selected patients with low rates of NAC removal. Some patients can preserve the NAC sensation. Long-term outcome should receive follow-up.